ACRP Making 4-Year, $4 Million Investment in Training Program For Clinical Research Professionals
The Association of Clinical Research Professionals (ACRP) announced that over the next 4 years they'll be investing $4 million into the development of a new proprietary training curriculum designed for clinical research professionals.
The Association of Clinical Research Professionals (ACRP) announced that over the next 4 years they'll be investing $4 million into the development of a new proprietary training curriculum designed for clinical research professionals. The 80+ new courses--the first of which are expected in January 2014--will cover 14 topic areas, and be designed for multiple learning formats. The heaviest focus will be on eLearning and online courses, all of which are to be hosted on the new Learning Management System "that allows for administration, documentation, tracking, reporting, and delivery of eLearning training solutions."
ACRP's investment aims to position the organization as the preeminent provider of professional development resources for the clinical research enterprise.
Read the full release here.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
